PubRank

David M Weinstock

Author PubWeight™ 55.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 2010 3.27
2 BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood 2012 2.91
3 Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci U S A 2009 2.73
4 Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 2009 2.54
5 A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol Cell 2008 2.28
6 A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 2013 2.14
7 Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev Cell 2009 2.12
8 Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003 2.09
9 The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. J Cell Biol 2010 1.80
10 Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition. J Exp Med 2012 1.65
11 Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation. Disaster Med Public Health Prep 2011 1.60
12 The evolution of influenza resistance and treatment. JAMA 2009 1.40
13 Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One 2013 1.32
14 Adamantane resistance in influenza A. JAMA 2006 1.25
15 BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair. Blood 2009 1.13
16 TSLP signaling network revealed by SILAC-based phosphoproteomics. Mol Cell Proteomics 2012 1.04
17 Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop. Stem Cells 2009 1.03
18 Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer Discov 2011 1.02
19 Allocation of scarce resources after a nuclear detonation: setting the context. Disaster Med Public Health Prep 2011 0.99
20 Inactivation of Uaf1 causes defective homologous recombination and early embryonic lethality in mice. Mol Cell Biol 2013 0.98
21 Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. Blood 2012 0.97
22 PARP1 is required for chromosomal translocations. Blood 2013 0.96
23 TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. Database (Oxford) 2014 0.93
24 The evolving contribution of hematopoietic progenitor cells to lymphomagenesis. Blood 2012 0.92
25 Repair at single targeted DNA double-strand breaks in pluripotent and differentiated human cells. PLoS One 2011 0.91
26 Triage and treatment tools for use in a scarce resources-crisis standards of care setting after a nuclear detonation. Disaster Med Public Health Prep 2011 0.89
27 t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not. Blood 2010 0.88
28 Medical planning and response for a nuclear detonation: a practical guide. Biosecur Bioterror 2012 0.87
29 The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell 2016 0.87
30 Scarce resources for nuclear detonation: project overview and challenges. Disaster Med Public Health Prep 2011 0.86
31 The transposase domain protein Metnase/SETMAR suppresses chromosomal translocations. Cancer Genet Cytogenet 2010 0.86
32 Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors. Biol Blood Marrow Transplant 2008 0.86
33 BCL2 suppresses PARP1 function and nonapoptotic cell death. Cancer Res 2012 0.86
34 Medical response to a nuclear detonation: creating a playbook for state and local planners and responders. Disaster Med Public Health Prep 2011 0.85
35 Medical management of radiation victims in the United States. Health Phys 2010 0.80
36 Next-generation cDNA screening for oncogene and resistance phenotypes. PLoS One 2012 0.80
37 Nosocomial central venous catheter infections among patients with different types of cancer. Infect Control Hosp Epidemiol 2002 0.79
38 Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents. Expert Rev Anti Infect Ther 2006 0.79
39 Assessing surge capacity for radiation victims with marrow toxicity. Biol Blood Marrow Transplant 2010 0.79
40 Using the model of resource and time-based triage (MORTT) to guide scarce resource allocation in the aftermath of a nuclear detonation. Disaster Med Public Health Prep 2011 0.79
41 Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia. Br J Haematol 2014 0.78
42 Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise. Health Phys 2015 0.78
43 Health care system planning for and response to a nuclear detonation. Disaster Med Public Health Prep 2011 0.77
44 Hepatitis C virus infection does not preclude standard breast cancer-directed therapy. Clin Breast Cancer 2009 0.77
45 Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2006 0.76
46 Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling. Cell Commun Signal 2013 0.75
47 Resource allocation after a nuclear detonation incident: unaltered standards of ethical decision making. Disaster Med Public Health Prep 2011 0.75
48 New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients. Expert Opin Pharmacother 2005 0.75
49 Corrigendum: PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA. Nat Commun 2017 0.75